These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2830784)

  • 1. Heart failure management: the impact of drug therapy on survival.
    Francis GS
    Am Heart J; 1988 Mar; 115(3):699-702. PubMed ID: 2830784
    [No Abstract]   [Full Text] [Related]  

  • 2. Current concepts in the treatment of congestive heart failure.
    Levine TB
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):147S-150S. PubMed ID: 6099731
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of chronic heart failure.
    Adorisio R; De Luca L; Rossi J; Gheorghiade M
    Heart Fail Rev; 2006 Jun; 11(2):109-23. PubMed ID: 16937030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
    Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.
    Fletcher RD; Cintron GB; Johnson G; Orndorff J; Carson P; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI49-55. PubMed ID: 8500239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III.
    Cohn JN
    Drugs; 1994; 47 Suppl 4():47-57; discussion 57-8. PubMed ID: 7523062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Ziesche S; Cobb FR; Cohn JN; Johnson G; Tristani F
    Circulation; 1993 Jun; 87(6 Suppl):VI56-64. PubMed ID: 8500241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of Left Ventricular Dysfunction (SOLVD)--new hope for heart failure.
    S Afr Med J; 1991 Nov; Suppl():1-8. PubMed ID: 1957226
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of cardiac failure in infants.
    George BL; Friedman WF
    Compr Ther; 1986 Feb; 12(2):8-14. PubMed ID: 3082585
    [No Abstract]   [Full Text] [Related]  

  • 11. V-HeFT positive for enalapril.
    Br J Hosp Med; 1991 Apr; 45(4):233. PubMed ID: 1676327
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.
    Johnson G; Carson P; Francis GS; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI32-9. PubMed ID: 8500237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.
    Daly P; Rouleau JL; Cousineau D; Burgess JH; Chatterjee K
    Br Heart J; 1986 Aug; 56(2):152-7. PubMed ID: 3524637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and traditional therapy of congestive heart failure. A European view.
    Bleifeld W; Kupper W; Hanrath P; Mathey D
    Am J Med; 1978 Jul; 65(1):203-7. PubMed ID: 685995
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons from recent randomized controlled trials for the management of congestive heart failure.
    Riegger GA
    Am J Cardiol; 1993 Jun; 71(17):38E-40E. PubMed ID: 8328366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New aspects in the treatment of acute cardiac insufficiency].
    Sterz H
    Wien Med Wochenschr; 1978 May; 128(9):256-61. PubMed ID: 27016
    [No Abstract]   [Full Text] [Related]  

  • 19. The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
    Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI1-4. PubMed ID: 8500232
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence-based treatment of chronic heart failure.
    Rosen D; Decaro MV; Graham MG
    Compr Ther; 2007; 33(1):2-17. PubMed ID: 17984487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.